UB Paderborn / Katalog / Suche / in CDI

Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges

Journal of thoracic oncology, 2019-03, Vol.14 (3), p.343-357

2019

Link zum Volltext

Verfügbarkeit prüfen

Reply to Wilson: Risk-Stratifying Pulmonary Nodules

American journal of respiratory and critical care medicine, 2021-01, Vol.203 (1), p.150-150

Massion, Pierre P

2021

Link zum Volltext

Verfügbarkeit prüfen

High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry

Proteomics (Weinheim), 2008-09, Vol.8 (18), p.3715-3724

2008

Link zum Volltext

Verfügbarkeit prüfen

xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression

Oncogene, 2018-09, Vol.37 (36), p.5007-5019

2018

Link zum Volltext

Verfügbarkeit prüfen

Tobacco smoking induces cardiovascular mitochondrial oxidative stress, promotes endothelial dysfunction, and enhances hypertension

American journal of physiology. Heart and circulatory physiology, 2019-03, Vol.316 (3), p.H639-H646

2019

Link zum Volltext

Verfügbarkeit prüfen

Assessing the Accuracy of a Deep Learning Method to Risk Stratify Indeterminate Pulmonary Nodules

American journal of respiratory and critical care medicine, 2020-07, Vol.202 (2), p.241-249

2020

Link zum Volltext

Verfügbarkeit prüfen

Intratumor Heterogeneity in Early Lung Adenocarcinoma

Frontiers in oncology, 2020-03, Vol.10, p.349-349

2020

Link zum Volltext

Verfügbarkeit prüfen

SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival

Clinical cancer research, 2013-02, Vol.19 (3), p.560-570

2013

Link zum Volltext

Verfügbarkeit prüfen

Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data

Nature reviews. Cancer, 2019-05, Vol.19 (5), p.289

2019

Link zum Volltext

Verfügbarkeit prüfen

ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers

Journal of clinical oncology, 2012-03, Vol.30 (8), p.863-870

2012

Link zum Volltext

Verfügbarkeit prüfen

Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study

JNCI : Journal of the National Cancer Institute, 2018-11, Vol.110 (11), p.1201-1207

2018

Link zum Volltext

Verfügbarkeit prüfen

Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis

Cancer cell, 2017-02, Vol.31 (2), p.286-299

2017

Link zum Volltext

Verfügbarkeit prüfen

Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial

PloS one, 2016-08, Vol.11 (8), p.e0159880-e0159880

2016

Link zum Volltext

Verfügbarkeit prüfen

Targeting SLC1a5‐mediated glutamine dependence in non‐small cell lung cancer

International journal of cancer, 2015-10, Vol.137 (7), p.1587-1597

2015

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive genomic profiles of small cell lung cancer

Nature (London), 2015-08, Vol.524 (7563), p.47-53

2015

Link zum Volltext

Verfügbarkeit prüfen

68Ga-DOTATATE PET/CT imaging of indeterminate pulmonary nodules and lung cancer

PloS one, 2017-02, Vol.12 (2), p.e0171301-e0171301

2017

Link zum Volltext

Verfügbarkeit prüfen

Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial

Chest, 2018-09, Vol.154 (3), p.491-500

2018

Link zum Volltext

Verfügbarkeit prüfen

Incorporating both genetic and tobacco smoking data to identify high-risk smokers for lung cancer screening

Carcinogenesis (New York), 2021-06, Vol.42 (6), p.874-879

2021

Link zum Volltext

Verfügbarkeit prüfen

Genomic Underpinnings of Tumor Behavior in In Situ and Early Lung Adenocarcinoma

American journal of respiratory and critical care medicine, 2020-03, Vol.201 (6), p.697-706

2020

Link zum Volltext

Verfügbarkeit prüfen

Reproducibility of Volumetric Computed Tomography of Stable Small Pulmonary Nodules with Implications on Estimated Growth Rate and Optimal Scan Interval

PloS one, 2015-09, Vol.10 (9), p.e0138144-e0138144

2015

Link zum Volltext

Verfügbarkeit prüfen

18F-FSPG PET imaging for the evaluation of indeterminate pulmonary nodules

PloS one, 2022, Vol.17 (3), p.e0265427-e0265427

2022

Link zum Volltext

Verfügbarkeit prüfen

Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement

American journal of respiratory and critical care medicine, 2017-10, Vol.196 (7), p.e15-e29

2017

Link zum Volltext

Verfügbarkeit prüfen

Integrative network analysis of early-stage lung adenocarcinoma identifies aurora kinase inhibition as interceptor of invasion and progression

Nature communications, 2022-03, Vol.13 (1), p.1592-1592, Article 1592

2022

Link zum Volltext

Verfügbarkeit prüfen

The state of molecular biomarkers for the early detection of lung cancer

Cancer prevention research (Philadelphia, Pa.), 2012-08, Vol.5 (8), p.992-1006

2012

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges

Reply to Wilson: Risk-Stratifying Pulmonary Nodules

High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry

xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression

Tobacco smoking induces cardiovascular mitochondrial oxidative stress, promotes endothelial dysfunction, and enhances hypertension

Assessing the Accuracy of a Deep Learning Method to Risk Stratify Indeterminate Pulmonary Nodules

Intratumor Heterogeneity in Early Lung Adenocarcinoma

SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival

Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data

ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers

Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study

Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis

Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial

Targeting SLC1a5‐mediated glutamine dependence in non‐small cell lung cancer

Comprehensive genomic profiles of small cell lung cancer

68Ga-DOTATATE PET/CT imaging of indeterminate pulmonary nodules and lung cancer

Emergence of a High-Plasticity Cell State during Lung Cancer Evolution

Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial

Incorporating both genetic and tobacco smoking data to identify high-risk smokers for lung cancer screening

Genomic Underpinnings of Tumor Behavior in In Situ and Early Lung Adenocarcinoma

Reproducibility of Volumetric Computed Tomography of Stable Small Pulmonary Nodules with Implications on Estimated Growth Rate and Optimal Scan Interval

18F-FSPG PET imaging for the evaluation of indeterminate pulmonary nodules

Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement

Integrative network analysis of early-stage lung adenocarcinoma identifies aurora kinase inhibition as interceptor of invasion and progression

The state of molecular biomarkers for the early detection of lung cancer

Suchergebnisse filtern